Abstract 4361877: Bismuth Nanoparticle-Infused Bioresorbable Graft Enables Multimodal Computed Tomography and Photoacoustic Imaging-Based Monitoring and Promotes Vascular Regeneration

A Allan John Barcena (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) M Marvin Bernardino (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) A Archana Mishra (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) D Dominic Karl Bolinas (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) K Kitz Paul Marco (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) K Kim Claudette Fernandez (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) E Erin Marie San Valentin (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) K Karem Court (Houston Methodist Research Institute, Houston, Texas, United States) B Biana Godin (Houston Methodist Research Institute, Houston, Texas, United States) N Natalie Fowlkes (Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center) R Richard Bouchard (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) S Steven Huang (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States) M Marites Melancon (The University of Texas MD Anderson Cancer Center, Houston, Texas, United States)

Abstract

Background: Bioresorbable polymeric grafts lack capabilities for non-invasive long-term monitoring, leading to late detection of complications like stenosis or aneurysm. Hence, we engineered a bioresorbable graft from poly(ε-caprolactone) (PCL) and bismuth nanoparticles (BiNPs). BiNPs are active on computed tomography (CT) and photoacoustic (PA) imaging, an emerging adjunct to ultrasound (US). This enables multimodal surveillance of placement, integrity, and resorption, offering the ability to assess performance, monitor regeneration, and facilitate timely intervention. Hypothesis: BiNP infusion would provide sustained, multimodal imaging capabilities without negatively impacting the graft's biocompatibility and capacity to support vascular regeneration. Methods: Synthesized BiNPs were infused into PCL to fabricate grafts via electrospinning. Grafts (autologous control, PCL, PCL-BiNP) were implanted in the abdominal aorta of Sprague Dawley rats (n=3 per group). Imaging was performed over 12 weeks. At 12 weeks, harvested grafts underwent multiplex immunofluorescence and spatial analysis of key vascular cell populations using Halo 4.0. Statistical significance was defined as p<0.05. Results: BiNP infusion reduced the grafts’ fiber diameter and pore area but maintained hemocompatibility, non-cytotoxicity, and maximum stress comparable to rat aorta. Over 12 weeks, the BiNP-infused grafts enabled serial in vivo monitoring via CT and US/PA imaging, achieved through the gradual release of BiNPs during graft resorption, which occurred without systemic organ accumulation. All grafts also exhibited comparable patency and flow characteristics. At week 12, PCL and PCL-BiNP showed endothelialization, cell density, and collagen content comparable to control. Spatial analysis revealed a confluent endothelial layer on the lumen of electrospun grafts and high-density smooth muscle cell clusters in the developing medial layer, indicating structured neotissue formation. PCL and PCL-BiNP grafts exhibited greater, diffuse immune cell and fibroblast densities than control, consistent with active macrophage resorption and early vascular remodeling. Overall, spatial patterns were similar between PCL and PCL-BiNP grafts, showing BiNP infusion enhanced monitoring without impairing regeneration. Conclusion: Novel BiNP-infused bioresorbable graft facilitates non-invasive serial monitoring via CT and US/PA imaging, while maintaining in vivo performance comparable to autologous grafts.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (13)

A

Allan John Barcena

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

M

Marvin Bernardino

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

A

Archana Mishra

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

D

Dominic Karl Bolinas

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

K

Kitz Paul Marco

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

K

Kim Claudette Fernandez

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

E

Erin Marie San Valentin

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

K

Karem Court

Houston Methodist Research Institute, Houston, Texas, United States

B

Biana Godin

Houston Methodist Research Institute, Houston, Texas, United States

N

Natalie Fowlkes

Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center

R

Richard Bouchard

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

S

Steven Huang

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

M

Marites Melancon

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States